University of Wisconsin–Madison
↗Madison, USA
The University of Wisconsin–Madison is a premier public research university and the flagship institution of the University of Wisconsin System. Founded in 1848, it is classified among 'R1: Doctoral Universities – Very high research activity' and consistently ranks as one of the top research spenders in the United States. The university is a global leader in life sciences, biotechnology, and medicine, housing the world-renowned Carbone Cancer Center and the School of Medicine and Public Health.
Commercialization of university research is managed by the Wisconsin Alumni Research Foundation (WARF), one of the oldest and most successful tech transfer offices in the world. UW-Madison is credited with pioneering discoveries in embryonic stem cells, vitamin D fortification, and the blood thinner Warfarin. The university maintains a massive ecosystem of clinical trials, interdisciplinary research centers, and biotechnology spinoffs, contributing over $30 billion annually to the Wisconsin economy.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Academic Research & Clinical Trials
SIZE & FINANCIALS
Employees:10000+
Revenue:$4.95B
Founded:1848
Ownership:government
Status:operating
FUNDING
Total Raised:$1.93B Annual Research Expenditure
Investors:National Science Foundation (NSF), National Institutes of Health (NIH), Department of Energy, Wisconsin Alumni Research Foundation (WARF)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (multiple licensed technologies)
Modalities:Cell therapy, Gene therapy, mRNA, Lipid nanoparticles, Small molecule, Radiopharmaceuticals
Active Trials:250
Trial Phases:Phase 1: 45 | Phase 2: 80 | Phase 3: 30 | Phase 4: 10
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Universities of Wisconsin
Subsidiaries:Wisconsin Alumni Research Foundation (WARF), Morgridge Institute for Research, UW Health, WiCell Research Institute
Key Partnerships:Abbott (Health & Blood Drive), SHINE Technologies (Radiopharmaceuticals), Mayo Clinic (Cancer Imaging Partnership), Promega (Biotech Collaboration)
COMPETITION
Position:Leader
Competitors:Johns Hopkins University, University of Michigan, Stanford University, UC San Francisco
LEADERSHIP
Key Executives:
Jennifer Mnookin - Chancellor
Dorota Grejner-Brzezinska - Vice Chancellor for Research
Scientific Founders:Harry Steenbock, James Thomson, Karl Paul Link
Board Members:Amy Bogost, Kyle Weatherly, Ashok Rai
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with University of Wisconsin–Madison. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.